Your browser doesn't support javascript.
loading
TIGIT and PD-1 Immune Checkpoint Pathways Are Associated With Patient Outcome and Anti-Tumor Immunity in Glioblastoma.
Raphael, Itay; Kumar, Rajeev; McCarl, Lauren H; Shoger, Karsen; Wang, Lin; Sandlesh, Poorva; Sneiderman, Chaim T; Allen, Jordan; Zhai, Shuyan; Campagna, Marissa Lynn; Foster, Alexandra; Bruno, Tullia C; Agnihotri, Sameer; Hu, Baoli; Castro, Brandyn A; Lieberman, Frank S; Broniscer, Alberto; Diaz, Aaron A; Amankulor, Nduka M; Rajasundaram, Dhivyaa; Pollack, Ian F; Kohanbash, Gary.
Affiliation
  • Raphael I; Department of Neurological Surgery, University of Pittsburgh, Pittsburgh, PA, United States.
  • Kumar R; Department of Neurological Surgery, University of Pittsburgh, Pittsburgh, PA, United States.
  • McCarl LH; Department of Neurological Surgery, University of Pittsburgh, Pittsburgh, PA, United States.
  • Shoger K; Department of Neurological Surgery, University of Pittsburgh, Pittsburgh, PA, United States.
  • Wang L; Departments of Neurological Surgery, University of California, San Francisco, CA, United States.
  • Sandlesh P; Department of Neurological Surgery, University of Pittsburgh, Pittsburgh, PA, United States.
  • Sneiderman CT; Department of Neurological Surgery, University of Pittsburgh, Pittsburgh, PA, United States.
  • Allen J; Department of Neurological Surgery, University of Pittsburgh, Pittsburgh, PA, United States.
  • Zhai S; University of Pittsburgh Medical Center (UPMC) Hillman Cancer Center Biostatistics Facility, University of Pittsburgh, Pittsburgh, PA, United States.
  • Campagna ML; Department of Neurological Surgery, University of Pittsburgh, Pittsburgh, PA, United States.
  • Foster A; Department of Neurological Surgery, University of Pittsburgh, Pittsburgh, PA, United States.
  • Bruno TC; Department of Pediatrics, University of Pittsburgh, Pittsburgh, PA, United States.
  • Agnihotri S; Department of Neurological Surgery, University of Pittsburgh, Pittsburgh, PA, United States.
  • Hu B; Department of Neurological Surgery, University of Pittsburgh, Pittsburgh, PA, United States.
  • Castro BA; Departments of Neurology, University of Chicago, Chicago, IL, United States.
  • Lieberman FS; Department of Neurology, University of Pittsburgh, Pittsburgh, PA, United States.
  • Broniscer A; Department of Pediatrics, Division of Health Informatics, Children's Hospital of Pittsburgh, University of Pittsburgh School of Medicine, Pittsburgh, PA, United States.
  • Diaz AA; Departments of Neurological Surgery, University of California, San Francisco, CA, United States.
  • Amankulor NM; Department of Neurological Surgery, University of Pittsburgh, Pittsburgh, PA, United States.
  • Rajasundaram D; Department of Pediatrics, Division of Health Informatics, Children's Hospital of Pittsburgh, University of Pittsburgh School of Medicine, Pittsburgh, PA, United States.
  • Pollack IF; Department of Neurological Surgery, University of Pittsburgh, Pittsburgh, PA, United States.
  • Kohanbash G; Department of Neurological Surgery, University of Pittsburgh, Pittsburgh, PA, United States.
Front Immunol ; 12: 637146, 2021.
Article in En | MEDLINE | ID: mdl-34025646

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Brain Neoplasms / Receptors, Immunologic / Glioblastoma / Programmed Cell Death 1 Receptor / Immune Checkpoint Inhibitors Type of study: Risk_factors_studies Limits: Animals / Humans Language: En Journal: Front Immunol Year: 2021 Document type: Article Affiliation country: United States Country of publication: Switzerland

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Brain Neoplasms / Receptors, Immunologic / Glioblastoma / Programmed Cell Death 1 Receptor / Immune Checkpoint Inhibitors Type of study: Risk_factors_studies Limits: Animals / Humans Language: En Journal: Front Immunol Year: 2021 Document type: Article Affiliation country: United States Country of publication: Switzerland